When was nContact Surgical founded?

nContact Surgical was founded in 2005 and raised its 1st funding round within a year of its incorporation.

Where is nContact Surgical located?

nContact Surgical is headquartered in Morrisville, United States.

How many employees does nContact Surgical have?

As of Jul 31, 2026, the latest employee count at nContact Surgical is 13.

Is nContact Surgical a funded company?

nContact Surgical is a funded company, having raised a total of $53.2M across 9 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jul 2005.

When was the latest funding round of nContact Surgical?

nContact Surgical's latest funding was a $***** Series E round on Mar 06, 2013, with participation from 0 investor. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $1.1B in funding in 2026 to date.

Where does nContact Surgical rank among its competitors?

nContact Surgical ranks 9th amongst 71 active competitors, of which 23 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was AtaCor Medical, which secured $75M in Oct, 2025.

Who are the top competitors of nContact Surgical?

nContact Surgical's top competitors include AtaCor Medical, EBR Systems and AtriCure. Among them, AtaCor Medical secured the most recent funding round in October, 2025.

nContact Surgical - 2026 Company Profile, Funding & Competitors

Q: Is nContact Surgical an acquired company?

nContact Surgical got acquired by AtriCure on Oct 05, 2015.

Company Details

nContant develops cardiac ablation devices. The company has developed EPi-Sense and Numeris Coagulation System and VisiTrax epicardial ablation device for treatment of atrial fibrillation. The EPi-Sense and Numeris Coagulation System with VisiTrax have CE Mark Approval in Europe for the coagulation of cardiac tissue for the treatment of atrial fibrillation and atrial flutter. It integrates suction, perfusion, and radiofrequency energy to ensure cardiac tissue contact and energy transmission to create linear lesions on a beating heart. Numeris with VisiTrax is also indicated for endoscopic coagulation of cardiac tissue in the United States.

Website: ncontactsurgical.com
Email ID: *****@ncontactsurgical.com
Phone Number: +1 **********

Key Metrics

Founded Year

2005

Location

Morrisville, United States

Stage

Acquired

Total Funding

$53.2M in 9 rounds

Latest Funding Round

Series E, Mar 06, 2013, $*****

Investors

Harbert Management & 6 more

Ranked

9^th among 71 active competitors

Employee Count

13 as on Jul 31, 2026

Similar Companies

AtaCor Medical & 90 more

Exit Details

Acquired by AtriCure (Oct 05, 2015)

View nContact Surgical's full profile

nContact Surgical got acquired by AtriCure on Oct 05, 2015 at an acquisition amount of $*****.

Click here to take a look at nContact Surgical's acquisition in detail

nContact Surgical has raised a total funding of $53.2M over 9 rounds. Its first funding round was on Jul 2005. nContact Surgical has 7 institutional investors.

Here is the list of recent funding rounds of nContact Surgical:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 06, 2013	4560574	Series E	1610497	2284356	9112318	2368340
Jan 20, 2012	7162523	Conventional Debt	4328607	2108249	4874118	3438737
Nov 10, 2010	7568650	Series D	2355616	2744069	Harbert Management	ZMV Associates

Access funding benchmarks and valuations. Sign up today!

View details of nContact Surgical's funding rounds and investors

nContact Surgical's employee count trend

nContact Surgical has 13 employees as of Jul 26. Here is nContact Surgical's employee count trend over the years:

Employee count trend for nContact Surgical

Uncover nContact Surgical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of nContact Surgical include AtaCor Medical, EBR Systems and AtriCure. Here is the list of Top 10 competitors of nContact Surgical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AtaCor Medical 2014, San Clemente (United States), Series D	Transforming cardiac rhythm management with innovative extravascular pacing and defibrillation solutions	$137M	aMoon, Broadview Ventures & 7 others	64/100
2nd	EBR Systems 2003, Sunnyvale (United States), Public	Revolutionizing cardiac rhythm management with leadless pacing technology for heart failure	$180M	Brandon Capital, M.H. Carnegie & Co & 12 others	60/100
3rd	AtriCure 2000, Mason (United States), Public	Medical device company focused on atrial fibrillation and pain management	-	Stage Capital, Camden Partners & 2 others	59/100
4th	CardioFocus 1990, Marlborough (United States), Series E	Endoscopically guided catheter for ablation	$261M	H.I.G. Capital, KBL & 22 others	58/100
5th	CathVision 2013, Copenhagen (Denmark), Series B	Provider and developer of an AI-based cardiac ablation therapy software and device	$36.1M	Vaekstfonden, Borean Innovation & 6 others	57/100
6th	Kestra Medical Technologies 2014, Kirkland (United States), Public	Device to protect and support patients at risk of cardiovascular disorders	$196M	Bain Capital Life Sciences, Longitude Capital ... & 9 others	54/100
7th	TyRx 1998, Monmouth Junction (United States), Acquired	Antibacterial envelopes for cardiac implants	$70.8M	MemorialCare Innovation Fund, HLM Venture Partners ... & 6 others	47/100
8th	Cameron Health 2001, San Clemente (United States), Acqui-Hired	Subcutaneous Implantable Defibrillator	$158M	Alloy Ventures, Western Technology Investment ... & 14 others	45/100
9th	nContact Surgical 2005, Morrisville (United States), Acquired	Cardiac ablation technology	$53.2M	Village Ventures, Finistere Ventures & 5 others	45/100
10th	Append Medical 2016, Or Yehuda (Israel), Series A	Developer of a device for the left atrial appendage closure system	$11.8M	ALIVE, Shoni Health Ventures & 3 others	45/100